St. Petersburg, Fla. – Fiedler & Associates is proud to introduce PGx testing. It’s a simple DNA test covered by Medicare and most insurance that promises to eliminate the current trial and error approach of prescribing medications. According to experts, 20% to 60% of the medications we take are ineffective and have a high failure rate due to genetic differences between patients.
In an interview with the press, Certified Representative of MedXPrime, Mike Fiedler, explained the advantages of this revolutionary test:
The test is called the Pharmacogenetic, or PGx test. It is an 8-year old science that alerts physicians in advance if there is a problem with a drug before prescribing it to a patient. This is incredible news, particularly for polypharmacy patients – those taking multiple medications.” According to Fiedler, patients need only to provide a sample of DNA to be tested which is quickly accomplished in your doctor’s office by a swab of the cheek. This simple test helps prevent any possible interaction with current and future drugs and can save money and lives.
It’s common knowledge that the more medications a patient takes, the more likely the risk of an adverse reaction. It’s estimated that the average Medicare patient takes between 5-8 medications per day, with some taking as many as 20. But most people are unaware of how pervasive the problem has become. The statistics are astounding: according to the FDA there are over 125,000 deaths and two million hospitalizations each year due to ADRs, causing them to rank as one of the top five causes of death in America.
And, as Fiedler points out, much of this could be prevented with this one simple test.
“This test is currently in regular practice at most major research hospitals such as the Mayo Clinic and St. Jude Children’s Research Hospital. It’s fast, easy, and most importantly, insured patients will never receive a bill,” said Fiedler.
The test covers 300+ common medications including 90 FDA black box labeled drugs as well as drug-to-drug, drug-to-food, and drug-to-alcohol interactions. This will help eliminate the need for guesswork in titrations or determining safe drugs and dosages.
The use of Pharmacogenetics is expected to grow at a rapid pace as healthcare providers learn the importance of determining a patient’s individual genetics before prescribing medications.
Individuals, social groups, hospitals, doctors, and other health care providers that are interested in learning more about the test or would like to schedule a group presentation are invited to contact Mike Fiedler directly or visit: www.pgxswabtest.com/pgx
Company Name: MedXPrime
Contact Person: Mike Fiedler
City: St. Petersburg
Country: United States